SENTA Partners lands on Inc. 5000 for fourth straight year

SENTA Partners ranked No. 3684 on the 2026 Inc. 5000 list, marking its fourth consecutive appearance among America’s fastest-growing private companies. The recognition comes as the ENT and allergy network expands across seven Southern states with 1,120 employees and 220 providers.

Why it matters: - SENTA Partners’ fourth straight Inc. 5000 honor underscores sustained growth in a competitive healthcare services market. - The ranking highlights the scale of SENTA’s expansion and its role as one of the country’s fastest-growing private companies. - The recognition may help reinforce SENTA’s position with physicians, partners and investors as it builds a larger ENT and allergy platform.

What happened: - SENTA Partners was named to the 2026 Inc. 5000 list at No. 3684. - The company received Inc. 5000 recognition for the fourth consecutive year. - The announcement was made Aug. 11, 2026, from Atlanta. - SENTA Partners is backed by Shore Capital Partners.

The details: - SENTA Partners says it is building a premier network of ENT and allergy practices across the U.S. through partnerships with leading physicians. - Since forming in 2019, SENTA Partners has completed 16 healthcare partnerships. - The company has grown to 1,120 employees, including 220 providers, across seven states in the Southern U.S. - SENTA says its growth strategy centers on physician leadership, innovation and a collaborative culture. - SENTA says its model combines clinical autonomy with operational support for partner practices. - CEO Conor Beardsley said the recognition reflects the work of physicians, providers and team members focused on ENT and allergy care. - Beardsley said the company’s purpose is helping people breathe better, hear better and live better. - Inc. ranks the 2026 list by percentage revenue growth from 2022 to 2025. - To qualify, companies had to be U.S.-based, privately held, for-profit and independent as of Dec. 31, 2025. - Inc. said the 5,000 companies on this year’s list had a median three-year revenue growth rate of 130% and added more than 627,208 jobs over the past three years. - More information is available from Inc. - More information is available from SENTA Partners. - SENTA Partners also links to its social presence on LinkedIn.

Between the lines: - The repeated Inc. 5000 placement suggests SENTA’s growth has been durable rather than one-off. - The company’s physician-centric structure appears designed to scale while preserving clinical control at the practice level. - Placement alongside a wide range of high-growth companies places healthcare services within a broader wave of U.S. entrepreneurial growth.

What's next: - SENTA Partners is likely to keep pursuing additional physician partnerships as it expands its ENT and allergy network. - The company’s next growth phase will likely depend on sustaining clinical quality while integrating new practices. - Further recognition could hinge on whether SENTA continues to balance expansion, operational support and physician autonomy.

The bottom line: - SENTA Partners is pairing steady acquisition-driven growth with a repeat spot on one of the best-known rankings in private business.